Pancreatic Cancer Research

ResearcherUniversity of JordanActive in the last 2 years

Malek Zihlif Zihlif

ORCID-verified (high confidence)As of 11 November 2026

Matched on ORCID iD 0000-0002-8005-3908; OpenAlex author ID A5070151087.

Their work

Papers
4 (first author 1, last author 2)
Trials
0
Grants
0
Labs led
1
Collaborators
5
Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper

Papers 4

  1. Enhancing chemosensitivity of PANC1 pancreatic cancer cells to gemcitabine using ANGTPL4, Notch1 and NF-κβ1 siRNAs. Last author DOI 10.2144/fsoa-2023-0145↗
  2. Alteration in the expression of the chemotherapy resistance‑related genes in response to chronic and acute hypoxia in pancreatic cancer. First author DOI 10.3892/br.2023.1670↗
  3. Effects of cyclic acute and chronic hypoxia on the expression levels of metabolism related genes in a pancreatic cancer cell line. Co-author DOI 10.3892/br.2022.1564↗
  4. Studying the Anti-Tumor Effects of siRNA Gene Silencing of Some Metabolic Genes in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.2174/1874467213666201012162250↗

Closest collaborators

The 5 strongest of 5 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Abdulfattah Al-Kadash · 1 shared paper, 2024
  2. Hana M. Hammad · 1 shared paper, 2023
  3. Nour Ali Obeidat · 1 shared paper, 2022
  4. Shtaywy Abdalla · 1 shared paper, 2022
  5. Ahmad S. Al Hanjori · 1 shared paper, 2021

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.